{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:37:37Z","timestamp":1776872257864,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,5]]},"DOI":"10.7759\/cureus.49978","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:03:46Z","timestamp":1701799426000},"source":"Crossref","is-referenced-by-count":2,"title":["Short-Term Efficacy and Adverse Effects of Sulfasalazine in the Management of Axial Spondyloarthropathy"],"prefix":"10.7759","author":[{"given":"Gauravi","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Sonawale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alhad","family":"Mulkalwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hritvik","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.33","article-title":"Diagnosis and classification in spondyloarthritis: identifying a chameleon","volume":"8","author":"van Tubergen A","year":"2012","unstructured":"van Tubergen A, Weber U. Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat Rev Rheumatol. 2012, 8:253-61. 10.1038\/nrrheum.2012.33","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208852","article-title":"The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis","volume":"75","author":"Deodhar A","year":"2016","unstructured":"Deodhar A, Strand V, Kay J, Braun J. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis. Ann Rheum Dis. 2016, 75:791-4. 10.1136\/annrheumdis-2015-208852","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21688","article-title":"Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?","volume":"64","author":"Kiltz U","year":"2012","unstructured":"Kiltz U, Baraliakos X, Karakostas P, et al.. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?. Arthritis Care Res (Hoboken). 2012, 64:1415-22. 10.1002\/acr.21688","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref4","article-title":"Ankylosing spondylitis: Interaction between genes, joints, age at onset, and disease expression","volume":"28","author":"Brophy S","year":"2001","unstructured":"Brophy S, Calin A. Ankylosing spondylitis: Interaction between genes, joints, age at onset, and disease expression. J Rheumatol. 2001, 28:2283-8.","journal-title":"J Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/014107687807100505","article-title":"Inherited susceptibility to rheumatic disease","volume":"71","author":"Brewerton DA","year":"1978","unstructured":"Brewerton DA. Inherited susceptibility to rheumatic disease. J R Soc Med. 1978, 71:331-8. 10.1177\/014107687807100505","journal-title":"J R Soc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005468.pub2","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","author":"Maxwell LJ","year":"2015","unstructured":"Maxwell LJ, Zochling J, Boonen A, et al.. TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015, CD005468. 10.1002\/14651858.CD005468.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado P","year":"2011","unstructured":"Machado P, Landew\u00e9 R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D. Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis. 2011, 70:47-53. 10.1136\/ard.2010.138594","journal-title":"Ann Rheum Dis"},{"key":"ref8","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index","volume":"21","author":"Calin A","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index. J Rheumatol. 1994, 21:2281-5.","journal-title":"J Rheumatol"},{"key":"ref9","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett S","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index. J Rheumatol. 1994, 21:2286-91.","journal-title":"J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit M","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, et al.. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011, 70:25-31. 10.1136\/ard.2010.133645","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13124","article-title":"A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis","volume":"21","author":"Khanna Sharma S","year":"2018","unstructured":"Khanna Sharma S, Kadiyala V, Naidu G, Dhir V. A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis. Int J Rheum Dis. 2018, 21:308-14. 10.1111\/1756-185X.13124","journal-title":"Int J Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.052878","article-title":"Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial","volume":"65","author":"Braun J","year":"2006","unstructured":"Braun J, Zochling J, Baraliakos X, et al.. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis. 2006, 65:1147-53. 10.1136\/ard.2006.052878","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310905","article-title":"Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial","volume":"31","author":"Nissil\u00e4 M","year":"1988","unstructured":"Nissil\u00e4 M, Lehtinen K, Leirisalo-Repo M, Luukkainen R, Mutru O, Yli-Kerttula U. Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum. 1988, 31:1111-16. 10.1002\/art.1780310905","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","article-title":"Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study","volume":"42","author":"Clegg DO","year":"1999","unstructured":"Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Arthritis Rheum. 1999, 42:2325-9. 10.1002\/1529-0131(199911)42:11&lt;2325::AID-ANR10&gt;3.0.CO;2-C","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15654","article-title":"Sulfasalazine-induced myopathy in a patient with an acute spondyloarthritis","volume":"52","author":"Caterson HC","year":"2022","unstructured":"Caterson HC, Youssef P. Sulfasalazine-induced myopathy in a patient with an acute spondyloarthritis. Intern Med J. 2022, 52:155. 10.1111\/imj.15654","journal-title":"Intern Med J"},{"key":"ref16","article-title":"Sulphasalazine lung toxicity: report of two cases","volume":"123","author":"Karmakar GC","year":"2010","unstructured":"Karmakar GC, Wong CA, Horwood F, Anderson G. Sulphasalazine lung toxicity: report of two cases. N Z Med J. 2010, 123:86-7.","journal-title":"N Z Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.01.006","article-title":"DRESS syndrome induced by sulphasalazine in rheumatoid arthritis","volume":"73","author":"Bejia I","year":"2006","unstructured":"Bejia I, Ben Hammouda S, Riahi K, Zinelabidine F, Mediouni B, Touzi M, Bergaoui N. DRESS syndrome induced by sulphasalazine in rheumatoid arthritis. Joint Bone Spine. 2006, 73:764-5. 10.1016\/j.jbspin.2006.01.006","journal-title":"Joint Bone Spine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4318\/tjg.2009.0032","article-title":"Sulfasalazine-induced hypersensitivity: a case report of DRESS syndrome","volume":"20","author":"Ye\u015filova Z","year":"2009","unstructured":"Ye\u015filova Z, Kantarcio\u011flu M, Er\u00e7in CN, et al.. Sulfasalazine-induced hypersensitivity: a case report of DRESS syndrome. Turk J Gastroenterol. 2009, 20:298-9. 10.4318\/tjg.2009.0032","journal-title":"Turk J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_129_18","article-title":"Sulfasalazine-induced drug rash with eosinophilia and systemic symptoms syndrome in a seronegative spondyloarthritis patient: a case report","volume":"53","author":"Sah N","year":"2021","unstructured":"Sah N, Ramaiah B, Koneri R. Sulfasalazine-induced drug rash with eosinophilia and systemic symptoms syndrome in a seronegative spondyloarthritis patient: a case report. Indian J Pharmacol. 2021, 53:391-3. 10.4103\/ijp.IJP_129_18","journal-title":"Indian J Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.12.1431","article-title":"Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis","volume":"39","author":"Nurmohamed MT","year":"2000","unstructured":"Nurmohamed MT, Soesan M, van Oers MH, Dijkmans BA, van Soesbergen RM. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis. Rheumatology (Oxford). 2000, 39:1431-3. 10.1093\/rheumatology\/39.12.1431","journal-title":"Rheumatology (Oxford)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.13703\/j.0255-2930.2016.11.014","article-title":"Acupuncture assisted by dynamic moxibustion for adult ankylosing spondylitis at early-to-mid stage (Article in Chinese)","volume":"36","author":"Chen ZL","year":"2016","unstructured":"Chen ZL, Pang GS. Acupuncture assisted by dynamic moxibustion for adult ankylosing spondylitis at early-to-mid stage (Article in Chinese). Zhongguo Zhen Jiu. 2016, 36:1157-60. 10.13703\/j.0255-2930.2016.11.014","journal-title":"Zhongguo Zhen Jiu"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.12200\/j.issn.1003-0034.2021.11.007","article-title":"Electronic focusing high-nergy extracorporeal shockwave combined with conventional oral medicine for the treatment of ankylosing spondylitis (Article in Chinese)","volume":"34","author":"Zhang WY","year":"2021","unstructured":"Zhang WY, Chen XT, Wang XQ, Zhang LL, Luo J. Electronic focusing high-nergy extracorporeal shockwave combined with conventional oral medicine for the treatment of ankylosing spondylitis (Article in Chinese). Zhongguo Gu Shang. 2021, 34:1020-4. 10.12200\/j.issn.1003-0034.2021.11.007","journal-title":"Zhongguo Gu Shang"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2022.120285","article-title":"The impact of intra-sacroiliac joint methylprednisolone injection in the recovery of patients with spondyloarthropathy: a randomized controlled trial","volume":"60","author":"Rajaei E","year":"2022","unstructured":"Rajaei E, Bavieh K, Mowla K, Ghorbani A, Movaffagh N. The impact of intra-sacroiliac joint methylprednisolone injection in the recovery of patients with spondyloarthropathy: a randomized controlled trial. Reumatologia. 2022, 60:332-9. 10.5114\/reum.2022.120285","journal-title":"Reumatologia"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20575","article-title":"Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S)","volume":"63 Suppl 11","author":"Zochling J","year":"2011","unstructured":"Zochling J. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken). 2011, 63 Suppl 11:S47-58. 10.1002\/acr.20575","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/203743-short-term-efficacy-and-adverse-effects-of-sulfasalazine-in-the-management-of-axial-spondyloarthropathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:25Z","timestamp":1707509545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/203743-short-term-efficacy-and-adverse-effects-of-sulfasalazine-in-the-management-of-axial-spondyloarthropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.49978","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,5]]}}}